The collagen type-1 alpha-1 (COL1A1) and platelet-derived growth factor beta chain (PDGFB) fusion uterine sarcoma is a relatively new entity that is not yet listed in the 2020 WHO classification of female genital tumors, with only a few cases reported [27]. Here, COL1A1 is linked to uterine corpus sarcoma.